KMTS

KMTS R&D to Revenue

20.48%Fiscal year

Period ending:

KMTS FY R&D/Revenue%
KMTS FY R&D/Revenue231.28%-24.78%
2020-04-302026-04-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

KMTS r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 6 observations from Apr 30, 2020 to Apr 30, 2026.

Kestra Medical Technologies Ltd R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
20.481%
26.1673%
55.6914%
206.5007%
0%
0%

Compare r&d to revenue

All KMTS financial metrics · KMTS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.